AAAAAA
Results: 1-25/26
Authors:
Rebuffat, A
Bernasconi, A
Ceppi, M
Wehrli, H
Verca, SB
Ibrahim, M
Frey, BM
Frey, FJ
Rusconi, S
Citation: A. Rebuffat et al., Selective enhancement of gene transfer by steroid-mediated gene delivery, NAT BIOTECH, 19(12), 2001, pp. 1155-1161
Authors:
Odermatt, A
Audige, A
Frick, C
Vogt, B
Frey, BM
Frey, FJ
Mazzucchelli, L
Citation: A. Odermatt et al., Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules, J AM S NEPH, 12(2), 2001, pp. 308-316
Authors:
Frey, FJ
Citation: Fj. Frey, The hypertensive patient with hypokalaemia: the search for hyperaldosteronism, NEPH DIAL T, 16(6), 2001, pp. 1112-1116
Authors:
Lanz, CB
Causevic, M
Heiniger, C
Frey, FJ
Frey, BM
Mohaupt, MG
Citation: Cb. Lanz et al., Fluid shear stress reduces 11 beta-hydroxysteroid dehydrogenase type 2, HYPERTENSIO, 37(1), 2001, pp. 160-169
Authors:
Lovati, E
Richard, A
Frey, BM
Frey, FJ
Ferrari, P
Citation: E. Lovati et al., Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease, KIDNEY INT, 60(1), 2001, pp. 46-54
Authors:
Mohaupt, MG
Vogt, B
Frey, FJ
Citation: Mg. Mohaupt et al., Sirolimus-associated eyelid edema in kidney transplant recipients, TRANSPLANT, 72(1), 2001, pp. 162-164
Authors:
Quattropani, C
Vogt, B
Odermatt, A
Dick, B
Frey, BM
Frey, FJ
Citation: C. Quattropani et al., Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis, J CLIN INV, 108(9), 2001, pp. 1299-1305
Authors:
Odermatt, A
Dick, B
Arnold, P
Zaehner, T
Plueschke, V
Deregibus, MN
Repetto, H
Frey, BM
Frey, FJ
Ferrari, P
Citation: A. Odermatt et al., A mutation in the cofactor-binding domain of 11 beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertensions, J CLIN END, 86(3), 2001, pp. 1247-1252
Authors:
Odermatt, A
Arnold, P
Frey, FJ
Citation: A. Odermatt et al., The intracellular localization of the mineralocorticoid receptor is regulated by 11 ss-hydroxysteroid dehydrogenase type 2, J BIOL CHEM, 276(30), 2001, pp. 28484-28492
Authors:
Heiniger, CD
Rochat, MK
Frey, FJ
Frey, BM
Citation: Cd. Heiniger et al., TNF-alpha enhances intracellular glucocorticoid availability, FEBS LETTER, 507(3), 2001, pp. 351-356
Authors:
Frey, FJ
Ferrari, P
Citation: Fj. Frey et P. Ferrari, Pastis and hypertension - what is the molecular basis?, NEPH DIAL T, 15(10), 2000, pp. 1512-1514
Authors:
Pfister, M
Schadeli, F
Buhler, M
Frey, FJ
Uehlinger, DE
Citation: M. Pfister et al., Novel dialysis cannulas: Are they worth the higher price tag?, AM J KIDNEY, 35(4), 2000, pp. 624-628
Authors:
Ferrari, P
Lovati, E
Frey, FJ
Citation: P. Ferrari et al., The role of the 11 beta-hydroxysteroid dehydrogenase type 2 in human hypertension, J HYPERTENS, 18(3), 2000, pp. 241-248
Authors:
Zaehner, T
Plueshke, V
Frey, BM
Frey, FJ
Ferrari, P
Citation: T. Zaehner et al., Structural analysis of the 11 beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease, KIDNEY INT, 58(4), 2000, pp. 1413-1419
Authors:
Frey, FJ
Citation: Fj. Frey, Nephrology 1999: Substantial Swiss contributions, SCHW MED WO, 130(1-2), 2000, pp. 32-34
Authors:
Frey, FJ
Citation: Fj. Frey, NFP34: Cooperation of complementary and mainstream medicine practitioners, FORSCH KOMP, 6, 1999, pp. 2-3
Authors:
Pfister, M
Jakob, SM
Marti, HP
Frey, FJ
Gugger, M
Citation: M. Pfister et al., Ambulatory nocturnal oximetry and sleep questionnaire-based findings in 38patients with end-stage renal disease, NEPH DIAL T, 14(6), 1999, pp. 1496-1502
Authors:
Schneider, DP
Marti, HP
Von Briel, C
Frey, FJ
Greiner, RH
Citation: Dp. Schneider et al., Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatin, ANN ONCOL, 10(6), 1999, pp. 677-683
Authors:
Frey, BM
Reber, BFX
Vishwanath, BS
Escher, G
Frey, FJ
Citation: Bm. Frey et al., Annexin I modulates cell functions by controlling intracellular calcium release, FASEB J, 13(15), 1999, pp. 2235-2245
Authors:
Pfister, M
Schaedeli, F
Frey, FJ
Uehlinger, DE
Citation: M. Pfister et al., Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis, BR J CL PH, 47(6), 1999, pp. 645-651
Authors:
Pfister, M
Jakob, S
Frey, FJ
Niederer, U
Schmidt, M
Marti, HP
Citation: M. Pfister et al., Judgment analysis in clinical nephrology, AM J KIDNEY, 34(3), 1999, pp. 569-575
Authors:
Ackermann, D
Vogt, B
Escher, G
Dick, B
Reichen, J
Frey, BM
Frey, FJ
Citation: D. Ackermann et al., Inhibition of 11 beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis, HEPATOLOGY, 30(3), 1999, pp. 623-629
Authors:
Frey, FJ
Citation: Fj. Frey, Nephrology 1998, SCHW MED WO, 129(1-2), 1999, pp. 17-19
Authors:
Vogt, B
Dick, B
N'Gankam, V
Frey, FJ
Frey, BM
Citation: B. Vogt et al., Reduced 11 beta-hydroxysteroid dehydrogenase activity in patients with thenephrotic syndrome, J CLIN END, 84(2), 1999, pp. 811-814
Authors:
Lovati, E
Ferrari, P
Dick, B
Jostarndt, K
Frey, BM
Frey, FJ
Schorr, U
Sharma, AM
Citation: E. Lovati et al., Molecular basis of human salt sensitivity: The role of the 11 beta-hydroxysteroid dehydrogenase type 2, J CLIN END, 84(10), 1999, pp. 3745-3749